Huntington National Bank’s PAR PHARMACEUTICAL COMPANIES INC PRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $50 | Hold |
1
| – | – | ﹤0.01% | 2914 |
|
|
2025
Q4 | $50 | Hold |
1
| – | – | ﹤0.01% | 2828 |
|
|
2025
Q3 | $50 | Hold |
1
| – | – | ﹤0.01% | 2908 |
|
|
2025
Q2 | $50 | Hold |
1
| – | – | ﹤0.01% | 2942 |
|
|
2025
Q1 | $50 | Hold |
1
| – | – | ﹤0.01% | 2975 |
|
|
2024
Q4 | $50 | Hold |
1
| – | – | ﹤0.01% | 3003 |
|
|
2024
Q3 | $50 | Hold |
1
| – | – | ﹤0.01% | 2995 |
|
|
2024
Q2 | $50 | Hold |
1
| – | – | ﹤0.01% | 2956 |
|
|
2024
Q1 | $50 | Hold |
1
| – | – | ﹤0.01% | 2796 |
|
|
2023
Q4 | $50 | Hold |
1
| – | – | ﹤0.01% | 2695 |
|
|
2023
Q3 | $50 | Hold |
1
| – | – | ﹤0.01% | 2677 |
|
|
2023
Q2 | $50 | Hold |
1
| – | – | ﹤0.01% | 2650 |
|
|
2023
Q1 | $50 | Hold |
1
| – | – | ﹤0.01% | 2492 |
|
|
2022
Q4 | $50 | Hold |
1
| – | – | ﹤0.01% | 2345 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 3090 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 3092 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 3018 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 2946 |
|
|
2021
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2668 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2556 |
|
|
2021
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2447 |
|
Huntington National Bank's PRX Position: Q1 2026 in Review
Huntington National Bank held its PAR PHARMACEUTICAL COMPANIES INC (PRX) position steady in Q1 2026 at 1 share worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #2914.
Huntington National Bank first reported a position in PRX in Q1 2021 and has held it in 21 quarters since. 1 fund tracked by Wall St. Rank holds PRX as of Q1 2026.
- Huntington National Bank held 1 share of PAR PHARMACEUTICAL COMPANIES INC worth $50 as of Q1 2026.
- Huntington National Bank left its PAR PHARMACEUTICAL COMPANIES INC share count unchanged in Q1 2026.
- PAR PHARMACEUTICAL COMPANIES INC made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2914 holding.
- Huntington National Bank first reported a position in PAR PHARMACEUTICAL COMPANIES INC in Q1 2021 and has held it in 21 quarters since.
- 1 fund tracked by Wall St. Rank held PAR PHARMACEUTICAL COMPANIES INC as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.